Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Johannes W. B. de Groot"'
Autor:
Marianne A. Jonker, Maaike de Boer, Nielka P. van Erp, Winald R. Gerritsen, Erik H.J.G. Aarntzen, Willem Grootjans, Yvonne Kamm, Sasja F. Mulder, Paul C. de Jong, Annelieke E.C.A.B. Willemsen, Johannes W. B. de Groot, Lioe-Fee de Geus-Oei, Jolien Tol, A. Vos, Carla M.L. van Herpen
Publikováno v:
Targeted Oncology, 13(5), 641-648
Targeted Oncology, 13, 5, pp. 641-648
Targeted Oncology, 13, 641-648
Targeted Oncology, 13(5), 641-648. Springer
Targeted Oncology, 13(5), 641-648. Springer, Cham
Targeted Oncology, 13, 5, pp. 641-648
Targeted Oncology, 13, 641-648
Targeted Oncology, 13(5), 641-648. Springer
Targeted Oncology, 13(5), 641-648. Springer, Cham
Background: Treating breast cancer patients with everolimus and exemestane can be challenging due to toxicity and suboptimal treatment responses. Objective: We investigated whether everolimus exposure and early metabolic response are predictors for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ccf1e7b498c51061039680e977524f0
https://hdl.handle.net/1887/78877
https://hdl.handle.net/1887/78877
Autor:
Youlia M. Kirova, Piotr J. Wysocki, Judy W. C. Ho, Ute Hamann, Dominique Stoppa-Lyonnet, Fernando Schmitt, Gulnur Guler, Zheng Shu, Neva E. Haites, Peter Simmonds, Cornelis J.M. Lips, Janis Gardovskis, Alain Fourquet, Evangelia Razis, Jean-Yves Pierga, Johannes W. B. de Groot, Siniša Radulović, Kay Huebner, Diana Eccles, Lidia Larizza, Åke Borg, Niklas Loman, Thangarajan Rajkumar, Peter T. Silberstein, Rita K. Schmutzler, Arvids Irmejs, Håkan Olsson, Rolf H. Sijmons, Lenka Foretova, Evgeny N. Imyanitov, Winette T. A. van der Graaf, Henry T. Lynch, Pål Møller, Pax H.B. Willemse, Pavel Elsakov, Vladimir Zajac, Jae-Gahb Park, Jacob Smeltzer, Walter P. Weber, P. Goetz, Mira Brankovic-Magic, Marianna Bitina, Gunta Purkalne, Andris Gardovskis, Drakoulis Yannoukakos
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary cancer in clinical practice, 5(3), 119-143. BioMed Central Ltd.
Hereditary cancer in clinical practice, 5(3), 119-143. BioMed Central Ltd.
BRCA1-associated cancers differ from non-hereditary cancers for many factors, including somatic mutation. It can be a subject of discussion that the natural history and response to treatment also may differ between the hereditary and sporadic subgrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fa7bf5d7213e50c893973500b13bc6
http://europepmc.org/articles/PMC2736985
http://europepmc.org/articles/PMC2736985
